Recent

% | $
Quotes you view appear here for quick access.

Vical Incorporated Message Board

  • gofordna gofordna Mar 10, 2013 1:10 PM Flag

    On the radar

    nice to wake up on a Sunday and see that Motley Fool featured Vical's 31% price move, triggered by Vijay's presentation on Wednesday. I like free PR like this. Let's see if we've finally punched through the $3.75 wall that this MB has seen in this movie before. IMO we'll continue moving higher this month. Time will tell.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • time will tell. At some point in the next two years we will see that decimal point move to the right.

      • 1 Reply to samlhop
      • If A-7 is approved, I think VICL will be bought, and I think it is worth much more to BMY than medarex was, even with MDX1106 in the pipeline. I think $2.4 would be the lowest tolerable price if A-7 hits, double that? We know that their basic technology works and is marketable, that is what Oncept means. A-7 working would mean that they have a viable platform for human gene therapy, as well as one worth while drug. They must have tons of propitiatory IP that is worth a mountain of cash and future revenues. All this hinges on A-7 working due to its proof of principle quality. I have a feeling that A-7 will beat both Yervoy and MDX1106 on several metrics, the only thing I can think of that would make this not true would be some kind of fraud, the last we have heard is that the event threshold has not yet been met.

    • roth capital conference presentation on 3/19

 
VICL
4.02+0.22(+5.79%)May 27 4:00 PMEDT